Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PSTI

Pluristem Therapeutics (PSTI) Stock Price, News & Analysis

Pluristem Therapeutics logo

About Pluristem Therapeutics Stock (NASDAQ:PSTI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.00
$1.58
52-Week Range
N/A
Volume
2,128 shs
Average Volume
715,259 shs
Market Capitalization
$32.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PSTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pluristem Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PSTI Stock News Headlines

NBRVF Nabriva Therapeutics plc
Pluri CEO Issues Shareholder Update
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

PSTI Stock Analysis - Frequently Asked Questions

Pluristem Therapeutics Inc. (NASDAQ:PSTI) posted its quarterly earnings results on Monday, November, 8th. The biotechnology company reported ($0.36) EPS for the quarter, topping analysts' consensus estimates of ($0.41) by $0.05.

Pluristem Therapeutics's stock reverse split before market open on Thursday, July 25th 2019.The 1-10 reverse split was announced on Wednesday, July 24th 2019. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 24th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pluristem Therapeutics investors own include NVIDIA (NVDA), Inovio Pharmaceuticals (INO), Teva Pharmaceutical Industries (TEVA), Meta Platforms (META), Gilead Sciences (GILD), Novavax (NVAX) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/08/2021
Today
7/14/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PSTI
CIK
1158780
Employees
153
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
($1.47)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.87 million
Net Margins
N/A
Pretax Margin
-20,024.79%
Return on Equity
-100.63%
Return on Assets
-55.46%

Debt

Debt-to-Equity Ratio
0.57
Current Ratio
8.22
Quick Ratio
8.22

Sales & Book Value

Annual Sales
$20 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
32,348,000
Free Float
30,601,000
Market Cap
$32.35 million
Optionable
Optionable
Beta
1.91

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PSTI) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners